AU Morning Wrap: ASX falls, AUB completes $350m equity deal
G'day, mooers! Check out the latest news on today's stock market!
• US stocks finished sharply lower
• Australian shares slumped on Tuesday; ASX 200 dropped 2.35per cent
• Stocks to watch: AUB, Pendal, Imugene
- moomoo News AU
Wall Street Summary
The most punishing market selloff in years showed no signs of abating Monday, with U.S. stock indexes sliding to new lows for 2022 and other assets.
The $S&P 500 Index (.SPX.US)$ slumped 132 points or 3.2 per cent, closing below 4,000 for the first time since March 2021. The decline extended the benchmark's retreat from its peak to 17 per cent.The $Dow Jones Industrial Average (.DJI.US)$ shed 654 points or 1.99 per cent. The $Nasdaq Composite Index (.IXIC.US)$ swooned 521 points or 4.29 per cent.
AU Market Watch
Australia's S&P/ASX 200 is set to extend its losses after Wall Street's rout continued with key indexes hitting 2022 lows. ASX futures are down 1.4%. Locally, household spending, retail trade and business turnover data are expected.
Australian shares opened lower this morning. The $S&P/ASX 200 (.XJO.AU)$ lost 2.35 per cent to 6953 as of 10:17 am.
The most punishing market selloff in years showed no signs of abating Monday, with U.S. stock indexes sliding to new lows for 2022 and other assets.
The $S&P 500 Index (.SPX.US)$ slumped 132 points or 3.2 per cent, closing below 4,000 for the first time since March 2021. The decline extended the benchmark's retreat from its peak to 17 per cent.The $Dow Jones Industrial Average (.DJI.US)$ shed 654 points or 1.99 per cent. The $Nasdaq Composite Index (.IXIC.US)$ swooned 521 points or 4.29 per cent.
AU Market Watch
Australia's S&P/ASX 200 is set to extend its losses after Wall Street's rout continued with key indexes hitting 2022 lows. ASX futures are down 1.4%. Locally, household spending, retail trade and business turnover data are expected.
Australian shares opened lower this morning. The $S&P/ASX 200 (.XJO.AU)$ lost 2.35 per cent to 6953 as of 10:17 am.
Stocks to Watch
$AUB Group Ltd (AUB.AU)$: Listed insurance aggregator AUB completed a $350 million fully underwritten equity raising to fund the $880 million acquisition of Tysers.
$Pendal Group Ltd (PDL.AU)$: Pendal Group's revenues rose 31 per cent to $362.6 million in the half year ending in March, with the increase reflecting the acquisition of TSW and higher global equity markets.
$Imugene Ltd (IMU.AU)$: Biotech company Imugene has received human research ethics committee (HREC) approval to begin a phase 2 clinical trial of its immunotherapy candidate, HER-Vaxx, in Australia.
Ex-dividend Companies: $United Overseas Australia Ltd (UOS.AU)$
Dividends Paid Companies: $Duratec Ltd (DUR.AU)$
Commodities
• Iron ore futures -4.7% to US$131.99 a tonne.
• Oil prices dipped in-line with broad-based selloff.
• Gold struggled for upside as investors dumped stocks and favoured safe havens like the US dollar and bonds.
Source: Dow Jones Newswires, Market Index
$AUB Group Ltd (AUB.AU)$: Listed insurance aggregator AUB completed a $350 million fully underwritten equity raising to fund the $880 million acquisition of Tysers.
$Pendal Group Ltd (PDL.AU)$: Pendal Group's revenues rose 31 per cent to $362.6 million in the half year ending in March, with the increase reflecting the acquisition of TSW and higher global equity markets.
$Imugene Ltd (IMU.AU)$: Biotech company Imugene has received human research ethics committee (HREC) approval to begin a phase 2 clinical trial of its immunotherapy candidate, HER-Vaxx, in Australia.
Ex-dividend Companies: $United Overseas Australia Ltd (UOS.AU)$
Dividends Paid Companies: $Duratec Ltd (DUR.AU)$
Commodities
• Iron ore futures -4.7% to US$131.99 a tonne.
• Oil prices dipped in-line with broad-based selloff.
• Gold struggled for upside as investors dumped stocks and favoured safe havens like the US dollar and bonds.
Source: Dow Jones Newswires, Market Index
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment